Serum Institute of India applies to DCGI to manufacture Sputnik V COVID vaccine, seeks indemnity
Amid discussions over possible legal protection to foreign vaccine manufacturers Pfizer and Moderna over their COVID-19 jabs in India, the SII has also sought protection against liabilities.
No comments:
Post a Comment